Sharp, a global leader in contract packaging, clinical supply services and small-scale sterile manufacturing, has announced plans for the expansion of its Macungie, PA site in North America to increase its production capacity for sterile injectables.
Cormica, has completed the seven-figure purchase of TPM Laboratories (TPM) in New Jersey. Cormica, backed by Limerston Capital, is focused on strategically expanding its capabilities across the U.S and Europe.
Around 2,000 people attended the 2024 edition of LogiPharma, the annual leading life sciences and supply chain event, making it the largest to date – with 70 percent of exhibition booths already booked for 2025.
Geert Vleugels, General Manager NL, Tjoapack, examines the driving forces behind PFS packaging innovations and highlights the need for partnerships with packaging experts to provide more patient-centric and safe therapies to patients.
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites.
Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organisation Aenova Group from leading international investment firm BC Partners.
Takeda have announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohn’s disease.
In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the market.
FUJIFILM Corporation have announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina.
Nandu Deorkar, Ph.D., MBA, senior vice president, research & development, biopharma production; and George Marquez, vice president, operations, Avantor, discuss advancing clinical trials manufacturing from pilot to production in our latest EPM issue.
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing.
